Conditions: Diffuse Large Cell Lymphoma; Burkitt’s Lymphoma; High Grade B-cell Lymphoma Interventions: Drug: Rituximab; Drug: IT Cytarabine

Principal Investigator:
Kirov, Ivan

Research Coordinator:
Laura Gates
(714) 509-8646

Visit clinicaltrials.gov for more information about this trial.



  • Clinical Trial Info
  • IRB Number: 1312114
  • Sponsor: NHL Consortium
  • Protocol Number: REBOOT ABLE
  • NCT Number: NCT01859819
  • Research Type: N/A
  • Phase: II
  • Status: Active - Open to Enrollment